Bone Marrow Transplantation Market Report 2026

Bone Marrow Transplantation Market Overview

• Bone Marrow Transplantation market size has reached to $12.11 billion in 2025 • Expected to grow to $15.96 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Increased Clinical Trials For Cell Therapy To Drive Bone Marrow Transplantation Market • Market Trend: Ossium Health And BE The Match Biotherapies Forge Strategic Partnership To Expand Bone Marrow Transplant Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bone Marrow Transplantation Market?

Bone marrow transplantation (BMT) is a specialized treatment for people suffering from certain malignancies or other conditions that involves replacing the bone marrow with healthy cells. The treatment is used to treat blood cell disorders such as leukemia and lymphoma. The main types of bone marrow transplantation are autologous bone marrow transplant and allogenic bone marrow transplant. An autologous bone marrow transplant is a medical technique that restores stem cells damaged by radiation or heavy doses of chemotherapy in a patient. The various indication are Hodgkin lymphoma, acute leukemia, multiple myelomas, solid tumors, non-Hodgkin lymphoma, and others, which are performed in hospitals, multispecialty clinics, and ambulatory surgical centers.

What Is The Bone Marrow Transplantation Market Growth Forecast?

The bone marrow transplantation market size is expected to see strong growth in the next few years. It will grow to $15.96 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to emerging stem cell technologies, integration of ai in patient matching, expansion of precision medicine applications, development of post-transplant supportive therapies, growth of emerging markets healthcare infrastructure. Major trends in the forecast period include personalized conditioning regimens, stem cell source optimization, post-transplant care innovations, donor matching and registry expansion, minimally invasive harvesting techniques.

Global Bone Marrow Transplantation Market Segmentation

1) By Type: Autologous Bone Marrow Transplant, Allogenic Bone Marrow Transplant 2) By Indication: Hodgkin Lymphoma, Acute Leukemia, Multiple Myelomas, Solid Tumors, Non-Hodgkin Lymphoma, Other Indications 3) By End-Users: Hospitals, Multispecialty Clinics, Ambulatory Surgical Centers Subsegments: 1) By Autologous Bone Marrow Transplant: Peripheral Blood Stem Cell Transplant, Bone Marrow Harvesting And Storage, Conditioning Regimens, Post-Transplant Care 2) By Allogenic Bone Marrow Transplant: Matched Sibling Donor Transplant, Matched Unrelated Donor Transplant, Haploidentical Transplant, Cord Blood Transplant, Conditioning Regimens, Post-Transplant Care

What Is The Driver Of The Bone Marrow Transplantation Market?

The growing clinical trials for cell therapy are expected to propel the growth of bone marrow transplantation going forward. Clinical trials for cell therapy involve research studies on human subjects to evaluate the safety and efficacy of using living cells to treat diseases or medical conditions. Clinical trials for cell therapy often utilize bone marrow transplantation due to its capacity to provide hematopoietic stem cells, essential for replacing damaged cells, treating blood disorders, and exploring novel cell-based treatments for various diseases. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the count of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the growing clinical trials for cell therapy will drive the bone marrow transplantation industry.

Key Players In The Global Bone Marrow Transplantation Market

Major companies operating in the bone marrow transplantation market are Merck Millipore Corporation, STEMCELL Technologies Inc., HemaCare Corporation, AllCells LLC, Lonza Group Ltd., Conversant Bio Company, Lifeline Cell Technology LLC, Mesoblast Ltd., PromoCell GmbH, ATCC Inc. (American Type Culture Collection), ReachBio LLC, Gamida Cell Ltd., Abbott Laboratories Inc., Allogene Therapeutics Inc., Amgen Inc., Angiocrine Biosciences Corp., Astellas Pharma Inc., Atara Biotherapeutics Inc., Bluebird Bio Inc., Cellectis S.A., Celyad SA, Erythrocyte Regeneration and Clinical Therapeutics Inc., Gammacell AB, Gilead Sciences Inc., Graphite Bio Inc., Incyte Corporation, Intellia Therapeutics Inc., Legend Biotech Corporation, Magenta Therapeutics Inc., Novartis AG

Global Bone Marrow Transplantation Market Trends and Insights

Major companies operating in the bone marrow transplantation industry are adopting strategic partnerships approach to enhance access to advanced technologies, broaden treatment options, and offer comprehensive transplant solutions. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in August 2023, Ossium Health, a US-based bioengineering company, partnered with Be the Match BioTherapies, a US-based provider of cell and gene therapy solutions. With this partnership, they aim to increase bone marrow transplant accessibility and treatment efficiency. This collaboration significantly amplifies Ossium's capacity to cater to patients on a larger scale, while enabling NMDP or Be The Match to extend a new lifeline of bone marrow to a broader spectrum of patients requiring life-saving treatments.

What Are Latest Mergers And Acquisitions In The Bone Marrow Transplantation Market?

In October 2024, Werfen, a Spain-based medical diagnostics company, acquired Omixon Bioinformatics Ltd. for $25 million. The acquisition aims to expand Werfen's portfolio in transplant diagnostics, enhancing precision and efficiency in bone marrow transplantation processes to improve patient outcomes. Omixon Bioinformatics Ltd. is a Hungary-based company specializing in transplant diagnostics, offering genetic and immunological testing solutions to ensure compatibility for organ and bone marrow transplants.

Regional Insights

North America was the largest region in the bone marrow transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global bone marrow transplantation market report forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bone Marrow Transplantation Market?

The bone marrow transplantation market includes revenues earned by providing transplantation services syngeneic transplants, allogeneic transplants, autologous transplants, haploidentical transplants, non-myeloablative transplants, and umbilical cord blood transplants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bone Marrow Transplantation Market Report 2026?

The bone marrow transplantation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bone marrow transplantation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.